Unlocking Innovation in Preclinical Research: The Rise of the In Vivo Contract Research Organization (CRO) Market

Fri, 18 Jul 2025 15:32:35 +0000

The In Vivo Contract Research Organization (CRO) market plays a pivotal role in the global pharmaceutical and biotechnology industry by offering essential services that support drug development, especially during the preclinical phase. These organizations conduct in vivo studies—research involving live animals—to determine the safety and efficacy of new therapeutic compounds before human trials begin. With growing R&D investments, an increasing demand for new drugs, and regulatory complexities, pharma and biotech firms are increasingly outsourcing to specialized CROs to optimize timelines and reduce costs.